The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Numis Raises GKN To Buy From Add

Tue, 29th Jul 2014 09:03

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
UBS RAISES AGGREKO PRICE TARGET TO 1675 (1550) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS ABERDEEN ASSET MANAGEMENT PRICE TARGET TO 510 (530) PENCE - 'BUY'
----------
SOCGEN CUTS ABERDEEN ASSET MANAGEMENT TO 'HOLD' ('BUY') - TARGET 465 PENCE
----------
TRADERS: MORGAN STANLEY CUTS ADMIRAL GROUP TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
TRADERS: BARCLAYS RAISES NATIONAL GRID PRICE TARGET TO 910 (885) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1500 (1730) PENCE - 'EQUAL WEIGHT'
----------
BERENBERG CUTS GLAXOSMITHKLINE PRICE TARGET TO 1520 (1740) PENCE - 'HOLD'
----------
NOMURA RAISES PRICE TARGET RECKITT BENCKISER TO 5400 (5300) PENCE - 'BUY'
----------
NUMIS CUTS RECKITT BENCKISER TO 'HOLD' ('ADD') - TARGET 5600 PENCE
----------
SOCGEN RAISES RECKITT BENCKISER PRICE TARGET TO 5300 (4750) PENCE - 'HOLD'
----------
BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 5000 (4800) PENCE - 'EQUAL WEIGHT'
----------
DEUTSCHE BANK CUTS HSBC PRICE TARGET TO 593 (640) PENCE - 'HOLD'
----------
CITIGROUP RAISES ASTRAZENECA PRICE TARGET TO 5400 (4900) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES ANGLO AMERICAN PRICE TARGET TO 1650 (1590) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES COMPASS GROUP PRICE TARGET TO 1105 (1025) PENCE - 'BUY'
----------
JPM RAISES STANDARD CHARTERED TO 'OVERWEIGHT' ('NEUTRAL') - PRICE TARGET 1450 (1350) PENCE
----------
JPMORGAN CUTS STANDARD LIFE PRICE TARGET TO 446 (454) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES GKN TO 'BUY' ('ADD') - TARGET 435 PENCE
----------
FTSE 250
----------
TRADERS: JEFFERIES RAISES BTG TO 'BUY' ('HOLD') - TARGET 760 (525) PENCE
----------
TRADERS: CITIGROUP RAISES AFRICAN BARRICK TARGET TO 236 (178) PENCE - 'SELL'
----------
SOCGEN CUTS TATE & LYLE PRICE TARGET TO 745 (760) PENCE - 'BUY'
----------
BARCLAYS CUTS RIGHTMOVE PRICE TARGET TO 2500 (3000) PENCE - 'OVERWEIGHT'
----------
CITIGROUP RAISES AFRICAN BARRICK GOLD PRICE TARGET TO 236 (178) PENCE - 'SELL'
----------
NUMIS RAISES AFRICAN BARRICK GOLD TO 'BUY' ('HOLD') - TARGET 330 (260) PENCE
----------
DEUTSCHE BANK CUTS HISCOX PRICE TARGET TO 646 (658) PENCE - 'SELL'
----------
CANACCORD RAISES HISCOX PRICE TARGET TO 710 (705) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS LADBROKES PRICE TARGET TO 165 (177) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS WILLIAM HILL PRICE TARGET TO 415 (435) PENCE - 'BUY'
----------
JPMORGAN RAISES PACE PLC PRICE TARGET TO 445 (437) PENCE - 'OVERWEIGHT'
----------
NUMIS CUTS PACE PLC PRICE TARGET TO 360 (420) PENCE - 'HOLD'
----------
NUMIS CUTS JARDINE LLOYD THOMPSON TO 'HOLD' ('ADD') - TARGET 1120 (1190) PENCE
----------
CANACCORD CUTS SPECTRIS TO 'HOLD' ('BUY') - TARGET 2,400 (2,700) PENCE
----------
CANACCORD CUTS INFORMA PRICE TARGET TO 515 (535) PENCE - 'HOLD'
----------
BERENBERG CUTS LANCASHIRE HLDGS PRICE TARGET TO 666 (720) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
CREDIT SUISSE RESUMES DAILY MAIL WITH 'OUTPERFORM' - TARGET 1040 PENCE
----------
CREDIT SUISSE INITIATES ZOOPLA PROPERTY WITH 'OUTPERFORM' - TP 290 PENCE
----------
BARCLAYS INITIATES ZOOPLA WITH 'OVERWEIGHT' - TARGET PRICE 315 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.



More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.